TAVISTOCK LIFE SCIENCES

tavistock-life-sciences-logo

Tavistock Life Sciences is a venture capital investment firm specialized in earl-stage investments.

#SimilarOrganizations #People #Financial #More

TAVISTOCK LIFE SCIENCES

Social Links:

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
LetsEncrypt Font Awesome Amazon Pound Sterling IIS 10 Microsoft ASP.NET 4.0 Microsoft Azure ASP.NET Ajax Smart App Banner


Similar Organizations

backswing-ventures-logo

Backswing Ventures

Backswing Ventures is a $50m venture fund investing in early stage companies in a broad range of industries.

riverfront-ventures-logo

Riverfront Ventures

Riverfront Ventures is a venture capital firm specializing in seed and early-stage investments.


Current Advisors List

not_available_image

Ivan Lieberburg Board Member @ Tavistock Life Sciences
Board_member

Current Employees Featured

not_available_image

Christopher Fuglesang
Christopher Fuglesang Team Member @ Tavistock Life Sciences
Team Member
2005-01-01

Investments List

Date Company Article Money raised
2018-10-17 Avidity Biosciences Tavistock Life Sciences investment in Series B - Avidity Biosciences 16 M USD
2018-04-03 Poseida Therapeutics Tavistock Life Sciences investment in Series B - Poseida Therapeutics 30.5 M USD
2016-05-11 G1 Therapeutics Tavistock Life Sciences investment in Series C - G1 Therapeutics 47 M USD
2015-08-24 Syndax Pharmaceuticals Tavistock Life Sciences investment in Series C - Syndax Pharmaceuticals 80 M USD
2015-03-12 Kura Oncology Tavistock Life Sciences investment in Private Equity Round - Kura Oncology 60 M USD
2014-11-12 Blueprint Medicines Tavistock Life Sciences investment in Series C - Blueprint Medicines 50 M USD
2014-04-16 Nexvet Tavistock Life Sciences investment in Series B - Nexvet 31.5 M USD
2012-11-21 MethylGene Tavistock Life Sciences investment in Venture Round - MethylGene 26.13 M USD
2009-07-08 Somaxon Pharmaceuticals Tavistock Life Sciences investment in Post-IPO Equity - Somaxon Pharmaceuticals 6 M USD
2009-04-01 Ambrx Tavistock Life Sciences investment in Series D - Ambrx 10 M USD

More informations about "Tavistock Life Sciences" on Search Engine